SEC Form SC 13D/A filed by BioRestorative Therapies Inc. (Amendment)
BioRestorative Therapies, Inc. |
(Name of Issuer)
|
Common Stock, $.0001 Par Value
|
(Title of Class of Securities)
|
090655606 |
(CUSIP Number)
|
Francisco Silva
40 Marcus Drive
Suite One
Melville, New York 11747
(631) 760-8100
|
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
|
February 13, 2024 |
(Date of Event which Requires Filing of this Statement)
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Francisco Silva
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☐
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
N/A
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
United States
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
764,557
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
764,557
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
764,557
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
10.7%
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN
|
|
|
|||
|
|
a. |
Name
Francisco Silva
|
b. |
Residence or Business Address
40 Marcus Drive, Suite One
Melville, New York 11747
|
c. |
Occupation
The Reporting Person is employed as the Vice President, Research and Development of the Company.
|
d. |
Convictions
The Reporting Person has not been convicted in a criminal proceeding in the last five years.
|
e. |
Civil Judgments
The Reporting Person has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
|
f. |
Citizenship
The Reporting Person is a citizen of the United States of America.
|
a. |
As of the date hereof, the Reporting Person is the beneficial owner of 764,557 shares of Common Stock of the Company (or approximately 10.7% of the outstanding Common Stock of the Company based upon there being 6,556,917 shares of Common
Stock of the Company outstanding as of February 13, 2024, based upon the number of shares of Common Stock outstanding as of November 10, 2023, as set forth in the Company's Quarterly Report on Form 10-Q for the period ended September 30,
2023, filed with the Securities and Exchange Commission on November 13, 2023, and the number of shares of Common Stock issued pursuant to the transaction discussed in the Company's Current Report on Form 8-K for an event dated February 6,
2024, filed with the Securities and Exchange Commission on February 8, 2024). Of such number, 587,777 shares of Common Stock are issuable upon the exercise of options that are exercisable currently or within 60 days and 12,136 shares of
Common Stock are held by the Reporting Person in a retirement trust.
|
b. |
The Reporting Person has sole voting and dispositive power over the 764,557 shares beneficially owned.
|
c. |
During the past 60 days, the Reporting Person has not effected any transactions in the Common Stock of the Company, except as reported in Item 4 hereof.
|
|
/s/ Francisco Silva
|
|
Francisco Silva
|
||
|